20

A triple agonist peptide studied for its activity at: GLP-1 receptors (associated with satiety signaling) GIP receptors (linked to metabolic modulation pathways) Glucagon receptors (involved in energy expenditure mechanisms) By targeting multiple metabolic pathways simultaneously, research models have explored its potential influence on appetite signaling, body weight regulation, and metabolic efficiency. The pre-loaded pen format enables precise subcutaneous administration, bypassing digestive breakdown and allowing structured protocol control in controlled research settings.